Quantcast
Channel: Atrial Fibrillation – The American Journal of Medicine Blog
Browsing latest articles
Browse All 25 View Live

Should Atrial Fibrillation Patients Take Oral Anticoagulants? (video)

A majority of atrial fibrillation patients who have not been treated oral anticoagulants (OAC) meet guideline indications for treatment. Untreated patients are at increased risk for adverse outcomes....

View Article



Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and...

Atrial fibrillation increases the risk of stroke by a factor of four- to fivefold, and dementia is a common consequence of stroke. However, atrial fibrillation has been associated with cognitive...

View Article

Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial...

Little is known about national patterns of anticoagulant use among patients with atrial fibrillation after the availability of direct oral anticoagulants (DOACs) and the associated implications for...

View Article

Monitoring of Apixaban in a Super Obese Patient

Direct oral anticoagulants (DOACs) are considered advantageous compared to vitamin K antagonists in eligible atrial fibrillation patients.1 Increased body weight is associated with 30% lower exposure...

View Article

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and...

Patients with nonvalvular atrial fibrillation commonly have comorbidities requiring concurrent use of oral anticoagulants and antiplatelets. There are no real-world data on the comparative safety of...

View Article


Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and...

  Patients with nonvalvular atrial fibrillation commonly have comorbidities requiring concurrent use of oral anticoagulants and antiplatelets. There are no real-world data on the comparative safety of...

View Article

Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients...

Nonvitamin K antagonist oral anticoagulants (NOACs) are alternatives to warfarin in patients with nonvalvular atrial fibrillation. Randomized trials compared NOACs with warfarin, but none have compared...

View Article

Mass Screening for Atrial Fibrillation: The Hype, The Methods, and The...

Recently, Apple launched new heart-related features for their Apple Watch, including an app cleared by the US Food and Drug Administration that notifies wearers if atrial fibrillation has occurred....

View Article


Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist...

The risks of thromboembolic and hemorrhagic events in patients with atrial fibrillation both increase with age; therefore, net clinical benefit analyses of anticoagulant treatments in the elderly...

View Article


Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants...

Direct oral anticoagulants (DOACs) reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation but may result in serious bleeding complications. Off-label...

View Article
Browsing latest articles
Browse All 25 View Live




Latest Images